Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program

Christopher M. O'Connor, Alan B. Miller, John E.A. Blair, Marvin A. Konstam, Patricia Wedge, Maria C. Bahit, Peter Carson, Markus Haass, Paul J. Hauptman, Marco Metra, Ron M. Oren, Richard Patten, Ileana Piña, Sherryn Roth, Jonathan D. Sackner-Bernstein, Brian Traver, Thomas Cook, Mihai Gheorghiade

Research output: Contribution to journalArticlepeer-review

184 Scopus citations

Fingerprint Dive into the research topics of 'Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program'. Together they form a unique fingerprint.

Medicine & Life Sciences